{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:14:10Z","timestamp":1791666850285,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Hospital District of Helsinki and Uusimaa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.humimm.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:13:25Z","timestamp":1617383605000},"page":"371-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pregnancy induced TMA in severe preeclampsia results from complement-mediated thromboinflammation"],"prefix":"10.1016","volume":"82","author":[{"given":"A. Inkeri","family":"Lokki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9833-3588","authenticated-orcid":false,"given":"Jenni","family":"Heikkinen-Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2021.03.006_b0005","article-title":"ACOG Practice Bulletin, Number 222","author":"Gestational Hypertension and Preeclampsia","year":"2020","journal-title":"Obstet. Gynecol."},{"issue":"5, Part 1","key":"10.1016\/j.humimm.2021.03.006_b0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.humimm.2021.03.006_b0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2013.05.009","article-title":"Complement activation in diseases presenting with thrombotic microangiopathy","volume":"24","author":"Meri","year":"2013","journal-title":"Eur. J. Internal Med."},{"key":"10.1016\/j.humimm.2021.03.006_b0020","article-title":"Traditional and new routes of trophoblast invasion and their implications for pregnancy diseases","volume":"21","author":"Huppertz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.humimm.2021.03.006_b0025","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.humimm.2021.03.006_b0030","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2393-13-110","article-title":"Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort","volume":"13","author":"Villa","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"10.1016\/j.humimm.2021.03.006_b0040","doi-asserted-by":"crossref","first-page":"a023473","DOI":"10.1101\/cshperspect.a023473","article-title":"Molecular mechanisms of preeclampsia","volume":"5","author":"Hod","year":"2015","journal-title":"Cold Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.humimm.2021.03.006_b0045","doi-asserted-by":"crossref","unstructured":"K. Yano, P.C. Liaw, J.M. Mullington, S.C. Shih, H. Okada, N. Bodyak, P.M. Kang, L. Toltl, B. Belikoff, J. Buras, B.T. Simms, J.P. Mizgerd, P. Carmeliet, S.A. Karumanchi, W.C. Aird, Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality, J. Exp. Med. 203 (2006) 1447\u20131458. doi: jem.20060375.","DOI":"10.1084\/jem.20060375"},{"issue":"2","key":"10.1016\/j.humimm.2021.03.006_b0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"CJASN"},{"issue":"6","key":"10.1016\/j.humimm.2021.03.006_b0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/nep.13234","article-title":"Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand: thrombotic microangiopathy in Aust\/NZ","volume":"23","author":"Fox","year":"2018","journal-title":"Nephrology"},{"issue":"12","key":"10.1016\/j.humimm.2021.03.006_b0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1160\/TH03-11-0683","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women","volume":"92","author":"S\u00e1nchez-Luceros","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.humimm.2021.03.006_b0065","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"CJASN"},{"issue":"10095","key":"10.1016\/j.humimm.2021.03.006_b0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.humimm.2021.03.006_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-8628(20000410)91:4<256::AID-AJMG3>3.0.CO;2-T","article-title":"Genetic effects on the liability of developing pre-eclampsia and gestational hypertension","volume":"91","author":"Salonen Ros","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.humimm.2021.03.006_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.a.30257","article-title":"Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study","volume":"130A","author":"Cnattingius","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.humimm.2021.03.006_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19733-6","article-title":"Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women","volume":"11","author":"Steinthorsdottir","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.humimm.2021.03.006_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/HYPERTENSIONAHA.117.09406","article-title":"Protective low-frequency variants for preeclampsia in the fms related tyrosine kinase 1 gene in the finnish population","volume":"70","author":"Lokki","year":"2017","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.humimm.2021.03.006_b0095","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.3895","article-title":"Variants in the fetal genome near FLT1 are associated with risk of preeclampsia","volume":"49","author":"McGinnis","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2021.03.006_b0100","doi-asserted-by":"crossref","unstructured":"J.E. Salmon, C. Heuser, M. Triebwasser, M.K. Liszewski, D. Kavanagh, L. Roumenina, D.W. Branch, T. Goodship, V. Fremeaux-Bacchi, J.P. Atkinson, Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE Cohort, PLoS Med. 8 (2011) e1001013. doi: 10.1371\/journal.pmed.1001013.","DOI":"10.1371\/journal.pmed.1001013"},{"key":"10.1016\/j.humimm.2021.03.006_b0105","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.03.006_b0110","doi-asserted-by":"crossref","first-page":"102872","DOI":"10.1016\/j.ebiom.2020.102872","article-title":"Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia","volume":"59","author":"Wedenoja","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60539-9","article-title":"Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype","volume":"10","author":"Banadakoppa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.humimm.2021.03.006_b0120","doi-asserted-by":"crossref","unstructured":"A. Lokki, L. Teiril\u00e4, M. Triebwasser, E. Daly, A. Bhattacharjee, L. Uotila, M.L. Asens, M. Kurki, M. Perola, K. Auro, J. Salmon, M. Daly, J. Atkinson, H. Laivuori, S. Fagerholm, S. Meri, Dysfunction of complement receptors CR3 (CD11b\/18) and CR4 (CD11c\/18) in preeclampsia: a genetic and functional study, BJOG An Int. J. Obstet. Gynaecol. (n.d.). (2021) doi:10.1111\/1471-0528.16660.","DOI":"10.1111\/1471-0528.16660"},{"key":"10.1016\/j.humimm.2021.03.006_b0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ebiom.2019.05.056","article-title":"Hyper-methylation of AVPR1A and PKC\u0392 gene associated with insensitivity to arginine vasopressin in human pre-eclamptic placental vasculature","volume":"44","author":"Gao","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humimm.2021.03.006_b0130","first-page":"1","article-title":"Analysis of complement C3 gene reveals susceptibility to severe Preeclampsia","volume":"8","author":"Inkeri Lokki","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/HYPERTENSIONAHA.117.10425","article-title":"Fetal microsatellite in the heme oxygenase 1 promoter is associated with severe and early-onset preeclampsia","volume":"71","author":"Kaartokallio","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.humimm.2021.03.006_b0140","doi-asserted-by":"crossref","unstructured":"S.E. Hiby, J.J. Walker, K.M. O\u2019Shaughnessy, C.W.G. Redman, M. Carrington, J. Trowsdale, A. Moffett, Combinations of maternal KIR and Fetal HLA-C Genes influence the risk of preeclampsia and reproductive success, J. Exp. Med. 200 (2004) 957\u2013965. doi:10.1084\/jem.20041214.","DOI":"10.1084\/jem.20041214"},{"key":"10.1016\/j.humimm.2021.03.006_b0145","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.jri.2020.103169","article-title":"Polymorphism in killer cell immunoglobulin-like receptors and human leukocyte antigen-c and predisposition to preeclampsia in Ethiopian pregnant women population","volume":"141","author":"Kelemu","year":"2020","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2021.03.006_b0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/imm.13289","article-title":"The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia","volume":"162","author":"Tao","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2021.03.006_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jri.2018.07.005","article-title":"The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia","volume":"129","author":"Johnsen","year":"2018","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.03.006_b0160","first-page":"287498","article-title":"A critical role for murine complement regulator crry in fetomaternal tolerance","volume":"(80-).","author":"Xu","year":"2000","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.humimm.2021.03.006_b0165","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mrd.21013","article-title":"Complement 3 deficiency impairs early pregnancy in mice","volume":"76","author":"Chow","year":"2009","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.humimm.2021.03.006_b0170","doi-asserted-by":"crossref","unstructured":"C. Agostinis, R. Bulla, C. Tripodo, A. Gismondi, H. Stabile, F. Bossi, C. Guarnotta, C. Garlanda, F. De Seta, P. Spessotto, A. Santoni, B. Ghebrehiwet, G. Girardi, F. Tedesco, An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development, J. Immunol. (Baltimore, Md. 1950). 185 (2010) 4420\u20134429. doi:10.4049\/jimmunol.0903215.","DOI":"10.4049\/jimmunol.0903215"},{"key":"10.1016\/j.humimm.2021.03.006_b0175","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/aji.12000","article-title":"Complement in pregnancy: a delicate balance","volume":"69","author":"Denny","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2021.03.006_b0185","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"10.1016\/j.humimm.2021.03.006_b0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.humimm.2021.03.006_b0195","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-017-0784-4","article-title":"The complement system and preeclampsia","volume":"19","author":"Regal","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.humimm.2021.03.006_b0200","doi-asserted-by":"crossref","unstructured":"R.M. Burwick, J.A. Vel\u00e1squez, C.M. Valencia, J. Guti\u00e9rrez-Mar\u00edn, F. Edna-Estrada, J.L. Silva, J. Trujillo-Ot\u00e1lvaro, J. Vargas-Rodr\u00edguez, Y. Bernal, A. Quintero, M. Rinc\u00f3n, J.E. Tolosa, Terminal complement activation in preeclampsia, Obstet. Gynecol. 132 (2018) 1. doi:10.1097\/AOG.0000000000002980.","DOI":"10.1097\/AOG.0000000000002980"},{"key":"10.1016\/j.humimm.2021.03.006_b0205","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/jcmm.13466","article-title":"Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia","volume":"22","author":"Ma","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.humimm.2021.03.006_b0210","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.humimm.2021.03.006_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02630","article-title":"The immunogenetic conundrum of preeclampsia","volume":"9","author":"Lokki","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2021.03.006_b0220","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/aji.12162","article-title":"Maternal and fetal alternative complement pathway activation in early severe preeclampsia","volume":"71","author":"Hoffman","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2021.03.006_b0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.preghy.2020.10.004","article-title":"Plasma CD59 concentrations are increased in preeclampsia with severe features and correlate with laboratory measures of end-organ injury","volume":"22","author":"Vel\u00e1squez","year":"2020","journal-title":"Pregnancy Hypertension"},{"key":"10.1016\/j.humimm.2021.03.006_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101337","article-title":"Regulation of the complement system and immunological tolerance in pregnancy","volume":"45","author":"Teiril\u00e4","year":"2019","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2021.03.006_b0240","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/labinvest.3780326","article-title":"Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women","volume":"81","author":"Reister","year":"2001","journal-title":"Lab. Invest."},{"issue":"10","key":"10.1016\/j.humimm.2021.03.006_b0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1389201019666180427110547","article-title":"The critical role of abnormal trophoblast development in the etiology of preeclampsia","volume":"19","author":"Huppertz","year":"2018","journal-title":"CPB"},{"key":"10.1016\/j.humimm.2021.03.006_b0250","first-page":"177","article-title":"The role of the spiral arteries in the pathogenesis of preeclampsia","volume":"1","author":"Brosens","year":"1972","journal-title":"Obstet. Gynecol. Annu."},{"issue":"3","key":"10.1016\/j.humimm.2021.03.006_b0255","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Labarrere","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.humimm.2021.03.006_b0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0940-9602(96)80102-6","article-title":"The fibrinoids of the human placenta: origin, composition and functional relevance","volume":"178","author":"Kaufmann","year":"1996","journal-title":"Ann. Anatomy \u2013 Anatomischer Anzeiger"},{"issue":"3","key":"10.1016\/j.humimm.2021.03.006_b0265","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.thromres.2009.09.013","article-title":"Platelet activation and endogenous thrombin potential in pre-eclampsia","volume":"125","author":"Macey","year":"2010","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.humimm.2021.03.006_b0270","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/HYPERTENSIONAHA.119.14280","article-title":"Hypertensive complications of pregnancy and risk of venous thromboembolism","volume":"75","author":"Scheres","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.humimm.2021.03.006_b0275","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10735-011-9351-5","article-title":"Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta","volume":"42","author":"Parra-Cordero","year":"2011","journal-title":"J. Mol. Hist."},{"issue":"4","key":"10.1016\/j.humimm.2021.03.006_b0280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/1607845412Y.0000000070","article-title":"Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia","volume":"18","author":"Aref","year":"2013","journal-title":"Hematology"},{"issue":"11","key":"10.1016\/j.humimm.2021.03.006_b0285","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.113.302280","article-title":"Human complement factor H is a reductase for large soluble von willebrand factor multimers\u2014brief report","volume":"33","author":"Nolasco","year":"2013","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.humimm.2021.03.006_b0290","doi-asserted-by":"crossref","unstructured":"S. Feng, X. Liang, M.A. Cruz, H. Vu, Z. Zhou, N. Pemmaraju, J.-F. Dong, M.H. Kroll, V. Afshar-Kharghan, The interaction between Factor H and Von Willebrand Factor, PLoS One. 8 (2013) e73715. doi:10.1371\/journal.pone.0073715.","DOI":"10.1371\/journal.pone.0073715"},{"key":"10.1016\/j.humimm.2021.03.006_b0295","doi-asserted-by":"crossref","unstructured":"J. Rayes, L.T. Roumenina, J.D. Dimitrov, Y. Repess\u00e9, M. Ing, O. Christophe, T.S. Jokiranta, L. Halbwachs-Mecarelli, A. Borel-Derlon, S. V. Kaveri, V. Fr\u00e9meaux-Bacchi, S. Lacroix-Desmazes, The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status, Blood. 123 (2014) 121\u2013125. doi: 10.1182\/blood-2013-04-495853.","DOI":"10.1182\/blood-2013-04-495853"},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0300","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.kint.2016.03.023","article-title":"Von Willebrand factor regulates complement on endothelial cells","volume":"90","author":"Noone","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.humimm.2021.03.006_b0305","doi-asserted-by":"crossref","unstructured":"N.A. Turner, J. Moake, Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis, PLoS One. 8 (2013) e59372. doi:10.1371\/journal.pone.0059372.","DOI":"10.1371\/journal.pone.0059372"},{"key":"10.1016\/j.humimm.2021.03.006_b0310","doi-asserted-by":"crossref","unstructured":"M. Endo, Y. Fuke, M. Tamano, M. Hidaka, I. Ohsawa, T. Fujita, H. Ohi, Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy, 97 (2004) c147-53. doi:10.1159\/000079174.","DOI":"10.1159\/000079174"},{"key":"10.1016\/j.humimm.2021.03.006_b0315","first-page":"S0002","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"6","author":"Burwick","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2010.10.007","article-title":"Preeclampsia and the anti-angiogenic state","volume":"1","author":"Agarwal","year":"2011","journal-title":"Pregnancy Hypert.: Int. J. Women's Cardiovasc. Health"},{"issue":"5","key":"10.1016\/j.humimm.2021.03.006_b0325","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2021.03.006_b0330","doi-asserted-by":"crossref","unstructured":"R.J. Levine, S.A. Karumanchi, Circulating angiogenic factors in preeclampsia, Clin. Obstet. Gynecol. 48 (2005) 372\u2013386. doi: 00003081-200506000-00015.","DOI":"10.1097\/01.grf.0000160313.82606.d7"},{"key":"10.1016\/j.humimm.2021.03.006_b0335","doi-asserted-by":"crossref","unstructured":"G. Girardi, D. Yarilin, J.M. Thurman, V.M. Holers, J.E. Salmon, Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction, J. Exp. Med. 203 (2006) 2165\u20132175. doi: jem.20061022.","DOI":"10.1084\/jem.20061022"},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1681\/ASN.2014121165","article-title":"ADAMTS13 endopeptidase protects against vascular endothelial growth factor inhibitor\u2013induced thrombotic microangiopathy","volume":"27","author":"Erpenbeck","year":"2016","journal-title":"JASN"},{"issue":"7","key":"10.1016\/j.humimm.2021.03.006_b0345","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.humimm.2021.03.006_b0350","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/HYPERTENSIONAHA.116.07252","article-title":"Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy","volume":"67","author":"Shahul","year":"2016","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.humimm.2021.03.006_b0355","doi-asserted-by":"crossref","first-page":"R1062","DOI":"10.1152\/ajpregu.00204.2018","article-title":"Residual vascular dysfunction in women with a history of preeclampsia","volume":"315","author":"Stanhewicz","year":"2018","journal-title":"Am. J. Physiol.-Regulatory, Integr. Comp. Physiol."},{"key":"10.1016\/j.humimm.2021.03.006_b0360","article-title":"Pre-eclampsia and risk of later kidney disease: nationwide cohort study","volume":"365","author":"Kristensen","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.humimm.2021.03.006_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003255","article-title":"Hypertensive disorders of pregnancy and the risk of chronic kidney disease: a Swedish registry-based cohort study","volume":"17","author":"Barrett","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.humimm.2021.03.006_b0370","doi-asserted-by":"crossref","unstructured":"C. Masias, S. Vasu, S.R. Cataland, None of the above: thrombotic microangiopathy beyond TTP and HUS, Blood. 129 (2017) 2857-2863. doi: 10.1182\/blood-2016-11-743104.","DOI":"10.1182\/blood-2016-11-743104"},{"key":"10.1016\/j.humimm.2021.03.006_b0375","doi-asserted-by":"crossref","unstructured":"F. Fakhouri, M. Scully, F. Prov\u00f4t, M. Blasco, P. Coppo, M. Noris, K. Paizis, D. Kavanagh, F. Pene, S. Quezada, A. Hertig, S. Kissling, P. O\u2019Brien, Y. Delmas, L. Alberio, N. Winer, A. Veyradier, S.R. Cataland, V. Fremeaux-Bacchi, C. Loirat, G. Remuzzi, V. Tsatsaris, Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group, Blood. 136 (2020) 9\u201311. doi:10.1182\/blood.2020005221.","DOI":"10.1182\/blood.2020005221"},{"key":"10.1016\/j.humimm.2021.03.006_b0380","doi-asserted-by":"crossref","unstructured":"A.J. Vaught, E.M. Braunstein, J. Jasem, X. Yuan, I. Makhlin, S. Eloundou, A.C. Baines, S.A. Merrill, S. Chaturvedi, K. Blakemore, C.J. Sperati, R.A. Brodsky, Germline mutations in the alternative pathway of complement predispose to HELLP syndrome, JCI Insight. 3 (2018) e99128. doi:10.1172\/jci.insight.99128.","DOI":"10.1172\/jci.insight.99128"},{"issue":"1","key":"10.1016\/j.humimm.2021.03.006_b0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82733-z","article-title":"Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics","volume":"11","author":"Youssef","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2021.03.006_b0390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.humimm.2021.03.006_b0395","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2021.03.006_b0400","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/1471-0528.16339","article-title":"Pre\u2010eclampsia\u2010like syndrome induced by severe COVID\u201019: a prospective observational study","volume":"127","author":"Mendoza","year":"2020","journal-title":"BJOG: Int. J. Obstet. Gy."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885921000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:53:53Z","timestamp":1759319633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885921000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0198885921000690"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2021.03.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy induced TMA in severe preeclampsia results from complement-mediated thromboinflammation","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}